We found that PTX administration improved cognitive deficits, enhanced antioxidative capability, and promoted mitochondrial biogenesis in D-gal-induced aging mice, which might be closely related to the upregulation of Nrf2 and PGC-1α through the cAMP-CREB pathway. This evidence concerns the gene PPARGC1A and Cognitive impairment.